Ayala Pharmaceuticals Inc (OTCMKTS:ADXS) Stock Gains Momentum: Here Is Why

March 6, 2023

Clinical stage oncology firm Ayala Pharmaceuticals Inc (OTCMKTS:ADXS) was one of the companies to have come into the news cycle this past Friday following a key announcement. The company announced that the Independent Data Monitoring Committee (IDMC) concerning the Phase 2/3 of the RINGSIDE study into its product AL102 had completed a prespecificed review of the data and recommended that the study could continue without any changes. Trading Data On…

Read More >>